182 related articles for article (PubMed ID: 11004622)
1. Photodamage pilot study: a double-blind, vehicle-controlled study to assess the efficacy and safety of tazarotene 0.1% gel.
Sefton J; Kligman AM; Kopper SC; Lue JC; Gibson JR
J Am Acad Dermatol; 2000 Oct; 43(4):656-63. PubMed ID: 11004622
[TBL] [Abstract][Full Text] [Related]
2. Histological effects of tazarotene 0.1% cream vs. vehicle on photodamaged skin: a 6-month, multicentre, double-blind, randomized, vehicle-controlled study in patients with photodamaged facial skin.
Machtinger LA; Kaidbey K; Lim J; Loven KH; Rist TE; Wilson DC; Parizadeh DD; Sefton J; Holland JM; Walker PS
Br J Dermatol; 2004 Dec; 151(6):1245-52. PubMed ID: 15606521
[TBL] [Abstract][Full Text] [Related]
3. A multicenter, randomized, double-blind trial of tazarotene 0.1% cream in the treatment of photodamage.
Kang S; Krueger GG; Tanghetti EA; Lew-Kaya D; Sefton J; Walker PS; Gibson JR;
J Am Acad Dermatol; 2005 Feb; 52(2):268-74. PubMed ID: 15692472
[TBL] [Abstract][Full Text] [Related]
4. Tazarotene 0.1% cream for the treatment of photodamage.
Phillips TJ
Skin Therapy Lett; 2004 Apr; 9(4):1-2. PubMed ID: 15146262
[TBL] [Abstract][Full Text] [Related]
5. Tazarotene 0.1% cream versus tretinoin 0.05% emollient cream in the treatment of photodamaged facial skin: a multicenter, double-blind, randomized, parallel-group study.
Lowe N; Gifford M; Tanghetti E; Poulin Y; Goldman M; Tse Y; Yamauchi P; Rosenzweig H; Kang S
J Cosmet Laser Ther; 2004 Jun; 6(2):79-85. PubMed ID: 15203997
[TBL] [Abstract][Full Text] [Related]
6. Effects of tazarotene 0.1 % cream in the treatment of facial acne vulgaris: pooled results from two multicenter, double-blind, randomized, vehicle-controlled, parallel-group trials.
Shalita AR; Berson DS; Thiboutot DM; Leyden JJ; Parizadeh D; Sefton J; Walker PS; Gibson JR;
Clin Ther; 2004 Nov; 26(11):1865-73. PubMed ID: 15639698
[TBL] [Abstract][Full Text] [Related]
7. Tazarotene cream for the treatment of facial photodamage: a multicenter, investigator-masked, randomized, vehicle-controlled, parallel comparison of 0.01%, 0.025%, 0.05%, and 0.1% tazarotene creams with 0.05% tretinoin emollient cream applied once daily for 24 weeks.
Kang S; Leyden JJ; Lowe NJ; Ortonne JP; Phillips TJ; Weinstein GD; Bhawan J; Lew-Kaya DA; Matsumoto RM; Sefton J; Walker PS; Gibson JR
Arch Dermatol; 2001 Dec; 137(12):1597-604. PubMed ID: 11735710
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of 0.1% tazarotene cream for the treatment of photodamage: a 12-month multicenter, randomized trial.
Phillips TJ; Gottlieb AB; Leyden JJ; Lowe NJ; Lew-Kaya DA; Sefton J; Walker PS; Gibson JR;
Arch Dermatol; 2002 Nov; 138(11):1486-93. PubMed ID: 12437455
[TBL] [Abstract][Full Text] [Related]
9. Tazarotene versus tazarotene plus hydroquinone in the treatment of photodamaged facial skin: a multicenter, double-blind, randomized study.
Lowe N; Horwitz S; Tanghetti E; Draelos Z; Menter A
J Cosmet Laser Ther; 2006 Sep; 8(3):121-7. PubMed ID: 16971360
[TBL] [Abstract][Full Text] [Related]
10. Comparison of tazarotene and minocycline maintenance therapies in acne vulgaris: a multicenter, double-blind, randomized, parallel-group study.
Leyden J; Thiboutot DM; Shalita AR; Webster G; Washenik K; Strober BE; Shupack J
Arch Dermatol; 2006 May; 142(5):605-12. PubMed ID: 16702498
[TBL] [Abstract][Full Text] [Related]
11. A status report on topical tazarotene in the management of acne vulgaris.
Del Rosso JQ; Tanghetti E
J Drugs Dermatol; 2013 Mar; 12(3):s53-8. PubMed ID: 23545935
[TBL] [Abstract][Full Text] [Related]
12. Tazarotene gel: efficacy and safety in plaque psoriasis.
Weinstein GD
J Am Acad Dermatol; 1997 Aug; 37(2 Pt 3):S33-8. PubMed ID: 9270554
[TBL] [Abstract][Full Text] [Related]
13. A clinical study of topical Pyratine 6 for improving the appearance of photodamaged skin.
McCullough JL; Garcia RL; Reece B
J Drugs Dermatol; 2008 Feb; 7(2):131-5. PubMed ID: 18335649
[TBL] [Abstract][Full Text] [Related]
14. Tazarotene 0.1% gel in the treatment of fingernail psoriasis: a double-blind, randomized, vehicle-controlled study.
Scher RK; Stiller M; Zhu YI
Cutis; 2001 Nov; 68(5):355-8. PubMed ID: 11766122
[TBL] [Abstract][Full Text] [Related]
15. Tazarotene cream for postinflammatory hyperpigmentation and acne vulgaris in darker skin: a double-blind, randomized, vehicle-controlled study.
Grimes P; Callender V
Cutis; 2006 Jan; 77(1):45-50. PubMed ID: 16475496
[TBL] [Abstract][Full Text] [Related]
16. The safety and efficacy of tazarotene gel, a topical acetylenic retinoid, in the treatment of psoriasis.
Krueger GG; Drake LA; Elias PM; Lowe NJ; Guzzo C; Weinstein GD; Lew-Kaya DA; Lue JC; Sefton J; Chandraratna RA
Arch Dermatol; 1998 Jan; 134(1):57-60. PubMed ID: 9449910
[TBL] [Abstract][Full Text] [Related]
17. Comparison of tazarotene 0.1% gel plus petrolatum once daily versus calcipotriol 0.005% ointment twice daily in the treatment of plaque psoriasis.
Tzung TY; Wu JC; Hsu NJ; Chen YH; Ger LP
Acta Derm Venereol; 2005; 85(3):236-9. PubMed ID: 16040409
[TBL] [Abstract][Full Text] [Related]
18. A pilot study to determine the effect of tazarotene gel 0.1% on steroid-induced epidermal atrophy.
Kaidbey K; Kopper SC; Sefton J; Gibson JR
Int J Dermatol; 2001 Jul; 40(7):468-71. PubMed ID: 11679006
[TBL] [Abstract][Full Text] [Related]
19. Tazarotene 0.1% gel for refractory mycosis fungoides lesions: an open-label pilot study.
Apisarnthanarax N; Talpur R; Ward S; Ni X; Kim HW; Duvic M
J Am Acad Dermatol; 2004 Apr; 50(4):600-7. PubMed ID: 15034511
[TBL] [Abstract][Full Text] [Related]
20. Topical retinoids in inflammatory acne: a retrospective, investigator-blinded, vehicle-controlled, photographic assessment.
Leyden JJ; Shalita A; Thiboutot D; Washenik K; Webster G
Clin Ther; 2005 Feb; 27(2):216-24. PubMed ID: 15811485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]